fluorouracil

You have access
Predictive Factors for Completion of TPF Induction Chemotherapy in Patients With Locally Advanced Head and Neck Cancer
KENJI NAKANO, AKIRA SETO, TORU SASAKI, WATARU SHIMBASHI, HIROFUMI FUKUSHIMA, HIROYUKI YONEKAWA, HIROKI MITANI and SHUNJI TAKAHASHI

Anticancer Research August 2019, 39 (8) 4337-4342; DOI: https://doi.org/10.21873/anticanres.13601
You have access
Pre-exposure to Fluorouracil Increased Trifluridine Incorporation and Enhanced its Anti-tumor Effect for Colorectal Cancer
TAISUKE BABA, TOSHIO KOKURYO, JUNPEI YAMAGUCHI, YUKIHIRO YOKOYAMA, KEISUKE UEHARA, TOMOKI EBATA and MASATO NAGINO

Anticancer Research March 2018, 38 (3) 1427-1434;
You have access
Effect of Hyperglycemia on Antitumor Activity and Survival in Tumor-bearing Mice Receiving Oxaliplatin and Fluorouracil
MAI IKEMURA and TOHRU HASHIDA

Anticancer Research October 2017, 37 (10) 5463-5468;
You have access
Relationship Between HSP70 and ERBB2 Expression in Breast Cancer Cell Lines Regarding Drug Resistance
LU YUE, JIN-YU XIANG, PING SUN, YA-SAI YAO, ZHEN-NI SUN, XIANG-PING LIU, HAI-BO WANG, ZAN SHEN and RU-YONG YAO

Anticancer Research March 2016, 36 (3) 1243-1249;
You have access
Neoadjuvant Chemotherapy with Divided-dose Docetaxel, Cisplatin and Fluorouracil for Patients with Squamous Cell Carcinoma of the Esophagus
TOSHIYASU OJIMA, MIKIHITO NAKAMORI, MASAKI NAKAMURA, MASAHIRO KATSUDA, KEIJI HAYATA, TOMOYA KATO, JUNYA KITADANI, HIROTAKA TABATA, AKIHIRO TAKEUCHI, MAKOTO IWAHASHI and HIROKI YAMAUE

Anticancer Research February 2016, 36 (2) 829-834;
You have access
Fluorouracil-induced Hyperammonemia in a Patient with Colorectal Cancer
SONIA AMIN THOMAS, NEVEEN TOMEH and STEPHANIE THEARD

Anticancer Research December 2015, 35 (12) 6761-6763;
You have access
Induction Chemotherapy Using FAP for Patients with Stage II/III Squamous Cell Carcinoma of the Esophagus
SHIGEYUKI TAMURA, ATSUSHI TAKENO, HIROKAZU TANIGUCHI, YOSHITERU KATSURA, YOSHIAKI OHMURA, YOSHINORI KAGAWA, HIDEKI SAKISAKA, YUTAKA TAKEDA and TAKESHI KATO

Anticancer Research May 2015, 35 (5) 2975-2982;
You have access
Liver Resectability of Advanced Liver-limited Colorectal Liver Metastases Following mFOLFOX6 with Bevacizumab (KSCC0802 Study)
TORU BEPPU, YASUNORI EMI, SHOJI TOKUNAGA, EIJI OKI, KEN SHIRABE, SHINICHI UENO, MASAFUMI KURAMOTO, AKIRA KABASHIMA, IKUO TAKAHASHI, HIRONORI SAMURA, SUSUMU EGUCHI, YOSHITO AKAGI, SHOJI NATSUGOE, YUTAKA OGATA, YOSHIHIRO KAKEJI, HIDEO BABA, YOSHIHIKO MAEHARA and KYUSHU STUDY GROUP OF CLINICAL CANCER (KSCC)

Anticancer Research November 2014, 34 (11) 6655-6662;
You have access
Matrix metalloproteinase-2 and -14 in p16-Positive and -Negative HNSCC after Exposure To 5-FU and Docetaxel In Vitro
CHRISTOPH ADERHOLD, CLAUDIA UMBREIT, ANNE FABER, RICHARD BIRK, JÖRG ULRICH SOMMER, KARL HÖRMANN and JOHANNES DAVID SCHULTZ

Anticancer Research September 2014, 34 (9) 4929-4937;
You have access
Cannabinoid Receptor Agonist as an Alternative Drug in 5-Fluorouracil-resistant Gastric Cancer Cells
XIANG-SHU XIAN, HYEYEON PARK, MYUNG-GYU CHOI and JAE MYUNG PARK

Anticancer Research June 2013, 33 (6) 2541-2547;

Main menu

User menu

Search

fluorouracil

Pages